TEL AVIV, Israel, Aug. 21, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...
TEL AVIV, Israel, Aug. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...
Bunions are small bony bumps on toes that cause tremendous pain. Surgery is the solution, but a traditional method is being challenged by a newer, groundbreaking procedure called a minimal ...
When compared with oxycodone IR in a post hoc analysis, cebranopadol demonstrated a larger magnitude of effect. Topline results were announced from a phase 3 trial evaluating cebranopadol for the ...
VX-548 selectively inhibits NaV1.8, a voltage-gated sodium channel that plays a critical role in pain signaling in the peripheral nervous system. Treatment with oral VX-548 resulted in a statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results